Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease-Reference-Cited by-同舟云学术

Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease

Published:2024-01 Issue: Volume:Volume 11 Page:145-157
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Miao Tongguo,Lou Xianzhe,Dong Shiming,Zhang Xiaoxiao,Guan Weiwei,Zhang Ying,Li Lu^ORCID,Yuan Xiwei,Ma Dong,Nan Yuemin

Publisher

Informa UK Limited

Reference52 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

3. Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides

4. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

5. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monocyte to high-density lipoprotein ratio based prognostic nomogram for patients following allogeneic vascular replacement pancreaticoduodenectomy;Frontiers in Genetics;2024-08-26

2. Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update;International Journal of Molecular Sciences;2024-03-26

3. Effect of Cytokeratin-18, C-peptide, MHR, and MACK-3 Biomarkers in Metabolic Dysfunction-Associated Fatty Liver Disease After Laparoscopic Sleeve Gastrectomy;Biomarker Insights;2024-01